These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7247455)

  • 1. Significance of renal brush border antibodies in skin immune complex-related diseases.
    Gengoux P; Lachapelle JM; Montplaisir S; Pelletier M
    Arch Dermatol Res; 1981; 270(2):175-8. PubMed ID: 7247455
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal tubule brush border antigens: failure to confirm a pathogenetic role in human membranous glomerulonephritis.
    Thorpe LW; Cavallo T
    J Clin Lab Immunol; 1980 Mar; 3(2):125-7. PubMed ID: 7009872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies directed against brush border antigens of proximal tubules in renal allograft recipients.
    Paul LC; Stuffers-Heiman M; van Es LA; de Graeff J
    Clin Immunol Immunopathol; 1979 Oct; 14(2):238-43. PubMed ID: 385194
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies reacting with brush borders of rat kidney tubules in sera from children with chronic hepatitis and chronic glomerulonephritis.
    Slusarczyk J; Michalak T
    Mater Med Pol; 1984; 16(1):15-7. PubMed ID: 6527567
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of anti-brush border antibody assay].
    Ohi H; Sakamoto K; Hatano M
    Nihon Rinsho; 1990 Feb; 48 Suppl():554-6. PubMed ID: 2192148
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated circulating CD40 ligand in patients with erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Caproni M; Antiga E; Parodi A; Schena D; Marzano A; Quaglino P; De Simone C; La Placa M; Volpi W; Del Biano E; Fabbri P
    Br J Dermatol; 2006 May; 154(5):1006-7. PubMed ID: 16634916
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum interleukin-13 levels are increased in patients with Stevens-Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme.
    Quaglino P; Caproni M; Osella-Abate S; Torchia D; Comessatti A; Del Bianco E; Antiga E; Frezzolini A; Schena D; Marzano A; De Simone C; Parodi A; Fabbri P; Bernengo MG
    Br J Dermatol; 2008 Jan; 158(1):184-6. PubMed ID: 17941938
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune complexes in erythema multiforme and the Stevens-Johnson syndrome.
    Wuepper KD; Watson PA; Kazmierowski JA
    J Invest Dermatol; 1980 May; 74(5):368-71. PubMed ID: 7391609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune response in erythema multiforme].
    Gombos F; Femiano F; Serpico R
    Arch Stomatol (Napoli); 1985; 26(4):431-6. PubMed ID: 3870302
    [No Abstract]   [Full Text] [Related]  

  • 10. [Finding of antibodies against Mycoplasma pneumoniae in some cases of exudative erythema multiforme].
    Binazzi M; Serra P; Miranda R
    G Ital Dermatol Minerva Dermatol; 1970 Mar; 45(3):134-5. PubMed ID: 5467660
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-brush border antibody].
    Endo M; Ohi H
    Nihon Rinsho; 1999 Nov; 57 Suppl():525-7. PubMed ID: 10635901
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
    Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phenomenon of macrophage aggregation activity in sera of patients with exfoliative erythroderma, erythema multiforme, and erythema nodosum.
    Krueger GG; Weston WL; Thorne EG; Mandel MJ; Jacobs RJ
    J Invest Dermatol; 1973 May; 60(5):282-5. PubMed ID: 4271331
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythema multiforme, Addison's disease, and Stevens-Johnson syndrome.
    Wermut W; Kubasik A
    Br Med J; 1972 Aug; 3(5825):531. PubMed ID: 5069630
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of autoantibodies against tubular brush border antigens in tubulointerstitial nephritis associated with Heymann nephritis.
    Kaji T; Yano S; Nojima Y; Naruse T
    Res Commun Mol Pathol Pharmacol; 1999; 104(1):53-62. PubMed ID: 10604278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excretion of kidney brush border antigens as a quantitative indicator of tubular damage.
    Scherberich JE; Mondorf WA
    Curr Probl Clin Biochem; 1979; (9):281-98. PubMed ID: 36259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephritogenic antibodies against kidney brush border glycoproteins in rabbits injected with Freund's adjuvant.
    Miettinen A
    Lab Invest; 1982 Jul; 47(1):67-75. PubMed ID: 7087399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunological characteristics of oculomucocutaneous disorders.
    Pleyer U; Niesen U; Mondino B
    Dev Ophthalmol; 1999; 30():62-83. PubMed ID: 10627917
    [No Abstract]   [Full Text] [Related]  

  • 20. Concurrence of erythema multiforme and erythema nodosum.
    Moreno AJ; Weisman I; Kenney RL; Fort SL
    Cutis; 1983 Mar; 31(3):275-8. PubMed ID: 6839804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.